Search results
Daily Brief: The Nvidia Rush
Quartz· 3 days agoFrance got a $16 billion cash infusion from the likes of Microsoft, Amazon, and Pfizer. Gold is still the first choice for many investors looking to...
One stock is dragging down the S&P 500's earnings growth
Yahoo Finance· 3 days agoWhen removing a few other companies from the sector, the S&P 500's earnings growth would shoot even...
JD Supra: Out from the Shadows: The SEC Succeeds on Shadow Insider Trading Theory
JD Supra· 7 hours agoThe Securities and Exchange Commission obtained a victory in a closely-watched trial when a jury found Matthew Panuwat liable for insider trading based on a “shadow trading” theory. The jury ...
Shadow Trading: How Far Can the SEC Expand the Insider Trading Prohibition? | New York Law Journal
Law.com· 1 day agoIn the 1980s, federal prosecutors vastly stretched the reach of the federal mail and wire fraud...
Nvidia Was Key to Success in My Stock-Picking Derby
GuruFocus.com via Yahoo Finance· 3 days agoIronically, crypto currencies play only a small role in Krout...contest picks for 2023-24 were Albemarle corp. (NYSE:ALB) and Pfizer Inc. (NYSE:PFE). He continues to like ...
The changing face of the Dow: See the names that have come and gone on the path to 40,000
CNBC· 9 hours agoMany companies have been added and removed in the more than 125 years of the Dow's existence.
Daily Brief: Quadruple the tariffs
Quartz· 3 days agoThe new tariffs, aimed at China’s electric vehicle makers, would make any automaker sweat. They’re slated to reach as high as 102.5%, up from 27.5%.
Amid Biotech Pitfalls, This Stock Has Outperformed Nvidia in the Last 3 Months
Investing.com· 4 days agoAmid Biotech Pitfalls, This Stock Has Outperformed Nvidia in the Last 3 Months
Unveiling Viatris (VTRS)'s Value: Is It Really Priced Right? A C
Guru Focus· 2 days agoWith a Loss Per Share of 0.06, the question arises: is Viatris modestly overvalued? This article delves into a detailed valuation analysis to help investors make informed decisions. Viatris ...
Biotech Behemoths: 3 Giants Set to Dominate the Health Scene
InvestorPlace· 3 days agoBiotechnology is an interesting place to look if you’re looking for growth and are not put off by...
